Aldeyra Therapeutics (ALDX) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
27 Apr, 2026Voting matters and shareholder proposals
Election of one Class III Director, with Todd C. Brady, M.D., Ph.D. nominated for the position.
Ratification of BDO USA, P.C. as the independent registered public accounting firm for the year ending December 31, 2026.
Advisory vote to approve the compensation of named executive officers.
Additional business may be addressed if properly brought before the meeting or any adjournment.
Board of directors and corporate governance
Board recommends voting in favor of all proposals presented at the annual meeting.
Executive compensation and say-on-pay
Shareholders are asked to approve, on a non-binding advisory basis, the compensation of named executive officers.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Aldeyra Therapeutics
- NDA resubmission for reproxalap in dry eye disease is planned after strong new trial results.ALDX
Jefferies Global Healthcare Conference 20259 Jul 2026 - Reproxalap nears FDA decision as a rapid-acting dry eye therapy, with major 2025 milestones ahead.ALDX
Jefferies London Healthcare Conference 20249 Jul 2026 - RASP platform expands into CNS, with ADX-248 and reproxalap advancing toward key milestones.ALDX
R&D Day 20258 Jul 2026 - FDA requests more efficacy data for reproxalap; NDA resubmission targeted for mid-2025.ALDX
Status Update8 Jul 2026 - Reproxalap achieved rapid, significant symptom relief in Phase 3 trial, enabling 2024 NDA resubmission.ALDX
Study Update8 Jul 2026 - Reproxalap approaches FDA approval with a robust pipeline advancing in immunology and retina.ALDX
Leerink’s Global Healthcare Conference 20252 Jul 2026 - Late-stage dry eye program nears key FDA decision, with strong cash and AbbVie partnership.ALDX
Jefferies Global Healthcare Conference 20264 Jun 2026 - Net loss narrowed to $3.5M as R&D and G&A expenses fell sharply; cash reserves at $65M.ALDX
Q1 20267 May 2026 - Proxy covers director election, auditor ratification, and say-on-pay, with strong governance focus.ALDX
Proxy filing27 Apr 2026